105 results
Page 3 of 6
SC TO-I
EX-99
293ch4kfjby uqw5pod
9 Nov 20
Issuer tender offer statement
9:01am
CORRESP
2kg4 p295gh
26 Jun 19
Correspondence with SEC
12:00am
8-K
EX-99.1
amaukn0i hiy
18 Apr 19
Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
4:06pm
8-K
EX-10.1
p36ibcqbm2gxljo7tz1
18 May 18
Departure of Directors or Certain Officers
12:00am